With a €2 billion valuation on the stock market and annual revenues of €1.2 billion, UDG Healthcare has the financial muscle to weather a storm. Plus, as the firm’s chief executive Brendan McAtamney acknowledges, with life expectancy and demographics increasing, UDG is operating in a safe harbor industry. The Dublin-based healthcare service provider employs 9,000 people in 29 countries and is organised across two divisions. The first, Sharp, is a global leader in contract clinical, manufacturing, packaging, and technology services. Sharp accounts for 30 per cent of UDG’s profits. The second, Ashfield, provides healthcare advisory, communications, commercial and clinical services,…

Want to read the full story?

Avail of our LIMTED TIME special offer and access this piece – and everything else on The Currency – for one month for just €1.

Subscribe

Cancel at any time.

Are you already a member? .